Healthcare / Medical Care FacilitiesNasdaqGS
$32.00
-2.25 (-6.57%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $30.3M · quality 37.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.1B
P/E
37.2x
↑EV/EBITDA
25.7x
↑ROE
8.9%
↑Gross Margin
13.8%
↓Debt/Equity
1.36
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2017–2025 · 8 años de histórico normalizado
Revenue CAGR
+18.1%
FCF CAGR
+12.5%
FCF margin
3.8%
FCF / Net income
1.23x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $947.7M · net income $29.6M · FCF $36.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | $947.7M | $947.7M | $695.2M | $544.9M | $473.2M | $439.7M | $391.0M | $338.5M | $286.1M | $251.0M |
| Net Income | $29.6M | $29.6M | $22.6M | $13.4M | $6.6M | $2.7M | $15.7M | $2.5M | $15.7M | $9.9M |
| EBITDA | $60.8M | $60.8M | $44.4M | $30.6M | $17.6M | $9.5M | $23.6M | $9.5M | $23.6M | $17.9M |
| EPS | 0.84 | 0.84 | 0.70 | 0.44 | 0.22 | 0.09 | 0.52 | 0.11 | 0.58 | 0.36 |
| Gross Margin | 13.8% | 13.8% | 13.5% | 12.3% | 12.4% | — | — | — | — | — |
| Operating Margin | 5.4% | 5.4% | 5.4% | 4.6% | 4.2% | 1.1% | 4.8% | 1.7% | 7.2% | 6.1% |
| Net Margin | 3.1% | 3.1% | 3.2% | 2.5% | 1.4% | 0.6% | 4.0% | 0.8% | 5.5% | 3.9% |
| Balance Sheet | ||||||||||
| Debt/Equity | 1.36 | 1.36 | 0.93 | 2.35 | 2.70 | — | — | — | — | — |
| Current Ratio | 1.19 | 1.19 | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||
| Free Cash Flow | $36.3M | $36.3M | $30.3M | $25.0M | $-5.1M | $-24.5M | $43.0M | $2.8M | $19.7M | $14.1M |
| Returns | ||||||||||
| ROE | 8.9% | 8.9% | 7.7% | 9.5% | 5.5% | — | — | — | — | — |
| Valuation | ||||||||||
| P/E | 37.21 | 37.21 | 37.91 | 34.89 | 47.55 | — | — | — | — | — |
| EV/EBITDA | 25.74 | 25.74 | 24.71 | 25.69 | 36.34 | — | — | — | — | — |
| P/B | 3.40 | 3.40 | 2.90 | 3.30 | 2.61 | — | — | — | — | — |
| Growth & Yield | ||||||||||
| Revenue Growth | 36.3% | 36.3% | 27.6% | 15.1% | — | 12.5% | 15.5% | 18.3% | 14.0% | — |
| EPS Growth | 20.0% | 20.0% | 59.1% | 100.0% | — | -82.7% | 372.7% | -81.0% | 61.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
50.1%
EPS terminal req.
$2.84
Spread vs growth
-30.1%
5Y implied EPS CAGR
32.5%
EPS terminal req.
$3.44
Spread vs growth
-12.5%
10Y implied EPS CAGR
20.7%
EPS terminal req.
$5.53
Spread vs growth
-0.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+11.5%
Start / end P/E
41.0x → 38.1x
EPS bridge
0.70 → 0.84
Residual
-1.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.